Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06751069 · ClinicalTrials.gov registry record · NA
Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
A NA study of Lung Fibrosis and Lung Interstitial Disease, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 460
- Enrollment target
- 4
- Study locations
NCT06751069: Recruiting NA study of Lung Fibrosis and Lung Interstitial Disease, sponsored by Mayo Clinic.
NCT06751069 is a NA study of Lung Fibrosis and Lung Interstitial Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 460 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06751069, a NA study of Lung Fibrosis and Lung Interstitial Disease, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 460 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this clinical trial is to determine the impact of a home-based pulmonary rehabilitation program with health coaching on patient-reported respiratory-related quality of life and physical activity, as compared to usual care in patients with fibrotic interstitial lung disease.
Primary Outcome
Respiratory-related quality of life questionnaire
Conditions Studied
Interventions
- BEHAVIORAL Home-based Pulmonary Rehab
Study Locations (4)
Minnesota
- University of Minnesota - Minneapolis
- Mayo Clinic in Rochester - Rochester
Arizona
- Mayo Clinic in Arizona - Scottsdale
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2030-09-30 |
| Phase | NA |
What NCT06751069 shows while recruiting
NCT06751069 is an interventional study that assigns participants to a tested intervention. The registered 460 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Lung Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Home-based Pulmonary Rehab is the first listed.
NCT06751069 reports a single indexed study location in Minnesota, Arizona, Florida.
Frequently Asked Questions
What is clinical trial NCT06751069 about?
NCT06751069 is a clinical study titled "Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease". The purpose of this clinical trial is to determine the impact of a home-based pulmonary rehabilitation program with health coaching on patient-reported respiratory-related quality of life and physical activity, as compared to usual care in patients with fibrotic interstitial lung disease.
What is the current status of trial NCT06751069?
This trial is currently recruiting. It is a NA study. The enrollment target is 460 participants. The study started on 2025-03-03. Estimated completion is 2030-09-30.
What conditions does trial NCT06751069 study?
This clinical trial studies the following conditions: Lung Fibrosis, Lung Interstitial Disease.
What interventions are being tested in trial NCT06751069?
The interventions under investigation include: Home-based Pulmonary Rehab (BEHAVIORAL).
Who is sponsoring clinical trial NCT06751069?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06751069 being conducted?
This trial has 4 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06751069's enrollment target sits among peer trials
460 222nd of 2000 higher than 1,778 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02977780 · 460 participants · Phase 2
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
- NCT03427736 · 460 participants
Anesthetics and Analgesics in Children
- NCT03819933 · 460 participants · NA
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
- NCT04621279 · 460 participants
Cool Prime Comparative Effectiveness Study for Mild HIE
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI